NCT06843720Recruiting
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
Source: ClinicalTrials.gov · Last updated 23 Jun 2026
Brief summary (registry, in English)
To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 7100 (estimated)
- First submitted
- 19 Feb 2025
- Start date
- 17 Feb 2025
- Primary completion date
- 31 Mar 2029
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Cervical cancer
- NCT number
- NCT06843720
What you commit to
- Study type: Interventional
- Planned participants: 7100
- From 17 Feb 2025 to the primary completion date, 31 Mar 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients eligible for cervical cancer screening:
- History of total hysterectomy
- History of cervical cancer
- Other study populations:
Other
- Report being currently pregnant
- Unable to communicate in English or Spanish
- Vulnerable Populations Participants/samples belonging to vulnerable populations (children, pregnant women, cognitively impaired adults, or prisoners) will be prohibited from participation.
Who the study is looking for
- Populations involved in the research are:
- stakeholder advisory board members;
- patients eligible for cervical cancer screening participating in the cluster randomized stepped-wedge trial;
- patients and community members participating in formative research activities;
- providers, clinic staff, and other health system stakeholders from partnering health systems;
- Project ECHO Participants (providers, clinic staff, and other health system stakeholders from partner and non-partner institutions);
- Other Clinical Networks (providers, clinic staff and other health system stakeholders from partner and non-partner institutions)
- The eligibility criteria for each are:
- Patients eligible for cervical cancer screening:
- Currently a resident in the state of Texas
- Attend for care at a partner clinic enrolled in the study
- Women and persons with a cervix
- Age 25-65
- Due or past due for cervical cancer screening
- Patients and community members participating in formative research activities:
- Purposively identified as a stakeholder for formative research by research staff
- Providers, clinic staff, and other health system stakeholders from partnering health systems:
- Employed at least part-time by a partnering health system
- Age 18+
- Project ECHO Participants:
- Participate in at least one Project ECHO session
- Age 18+
- Other Clinical Networks:
- Participate in at least one clinical network session
- Age 18+
Age in the registry: 18 years to 65 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.